Literature DB >> 15990532

Seven keys to relapse prevention in schizophrenia.

J S Lamberti1.   

Abstract

Relapse prevention is a primary goal in the treatment of schizophrenia. Relapse can cause significant personal distress, interfere with rehabilitation efforts, and result in psychiatric hospitalization. The emergence of psychotic symptoms and disruptive behaviors can also lead to arrest and incarceration, particularly among patients who are not engaged in treatment. This article focuses on the process of relapse in schizophrenia and theoretical foundations of relapse prevention. The Program for Relapse Prevention is presented, along with the results of a recently completed controlled prospective evaluation. Based upon this study and the current literature, the author presents a series of seven clinical strategies for optimal relapse prevention.

Entities:  

Year:  2001        PMID: 15990532     DOI: 10.1097/00131746-200107000-00006

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  5 in total

1.  Association between Medication Adherence and Duration of Outpatient Treatment in Patients with Schizophrenia.

Authors:  Seiichiro Tarutani; Hiroki Kikuyama; Munehiro Ohta; Tetsufumi Kanazawa; Takehiko Okamura; Hiroshi Yoneda
Journal:  Psychiatry Investig       Date:  2016-07-25       Impact factor: 2.505

2.  Qualitative process evaluation of a psycho-educational intervention targeted at people diagnosed with schizophrenia and their primary caregivers in Jordan.

Authors:  Abd Al-HadiHasan; Patrick Callaghan; Joanne S Lymn
Journal:  BMC Psychiatry       Date:  2017-02-13       Impact factor: 3.630

3.  Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): A randomized controlled trial.

Authors:  Dong Roman Xu; Shuiyuan Xiao; Hua He; Eric D Caine; Stephen Gloyd; Jane Simoni; James P Hughes; Juan Nie; Meijuan Lin; Wenjun He; Yeqing Yuan; Wenjie Gong
Journal:  PLoS Med       Date:  2019-04-23       Impact factor: 11.069

4.  Digital biomarkers from geolocation data in bipolar disorder and schizophrenia: a systematic review.

Authors:  Paolo Fraccaro; Anna Beukenhorst; Matthew Sperrin; Simon Harper; Jasper Palmier-Claus; Shôn Lewis; Sabine N Van der Veer; Niels Peek
Journal:  J Am Med Inform Assoc       Date:  2019-11-01       Impact factor: 4.497

5.  Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse.

Authors:  Emily Eisner; Christine Barrowclough; Fiona Lobban; Richard Drake
Journal:  BMC Psychiatry       Date:  2014-07-16       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.